Roxithromycin Export Market Intelligence: India's 78 Suppliers Shipping to 30 Countries — TransData Nexus 2026

Q: Who are the top roxithromycin exporters from India?

The top roxithromycin exporters from India are: 1. BRAWN LABORATORIES LIMITED — $1.3M (30.3% market share); 2. STRIDES PHARMA SCIENCE LIMITED — $758.8K (18.2% market share); 3. MARKSANS PHARMA LIMITED — $598.0K (14.3% market share); 4. TORRENT PHARMACEUTICALS LTD — $191.6K (4.6% market share); 5. GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED — $135.0K (3.2% market share). Together they account for 70.6% of India's total roxithromycin export value.

Q: What is the total export value of roxithromycin from India?

The total export value of roxithromycin from India is $4.2M USD, recorded across 427 shipment transactions from 78 active exporters to 30 destination countries. The average shipment value is $9.8K.

Q: Which countries import roxithromycin from India?

India exports roxithromycin to 30 countries worldwide. The top importing countries are: VIETNAM (33.9% share, $1.4M), CAMBODIA (18.3% share, $763.2K), AUSTRALIA (18.2% share, $758.8K), NEW ZEALAND (9.7% share, $405.4K), MYANMAR (5.6% share, $233.2K). These five markets account for 85.6% of total export value.

Q: What is the average price of roxithromycin exports from India?

The average unit price for roxithromycin exports from India is $14.67 USD per unit, with prices ranging from $0.02 to $274.21 depending on formulation, packaging, and order volume. The total market is valued at $4.2M across 427 shipments.

Q: Which ports handle roxithromycin exports from India?

The primary ports for roxithromycin exports from India are DELHI AIR CARGO ACC (INDEL4) (15.0% of shipments), SAHAR AIR CARGO ACC (INBOM4) (9.4% of shipments), SAHAR AIR (8.2% of shipments), Bombay Air (6.8% of shipments), NHAVA SHEVA SEA (INNSA1) (5.9% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of roxithromycin?

India is one of the world's leading exporters of roxithromycin due to its large base of 78 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports roxithromycin to 30 countries, demonstrating 15% global market coverage.

Q: What certifications do Indian roxithromycin exporters need?

Indian roxithromycin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import roxithromycin from India?

There are 125 registered buyers importing roxithromycin from India, spread across 30 countries. The repeat buyer rate is 51.2%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top roxithromycin supplier from India?

BRAWN LABORATORIES LIMITED is the leading roxithromycin exporter from India with a market share of 30.3% and total export value of $1.3M across 14 shipments. The top 5 suppliers together control 70.6% of total export value.

Suresh Sormare

Roxithromycin

India Pharmaceutical Trade Intelligence

$4.2M78 Suppliers30 CountriesHS 30049099

ExportsIndia → VIETNAM33.9%India → CAMBODIA18.3%

ImportsGERMANY → India$752

#1 Supplier: BRAWN LABORATORIES

Roxithromycin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Roxithromycin to the World

Between 2022 and 2026, India exported $4.2M worth of roxithromycin across 427 verified shipments to 30 countries — covering 15% of world markets in the Advanced Antibiotics segment. The largest destination is VIETNAM (33.9%). BRAWN LABORATORIES LIMITED leads with a 30.3% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Roxithromycin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Roxithromycin export data snapshot — $4.2M · 78 exporters · 30 countriesTransData Nexus · Indian Customs Data

Top Roxithromycin Exporters from India

78 active exporters · Ranked by export value

View all 78 →

Top Roxithromycin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	BRAWN LABORATORIES LIMITED	$1.3M	14	4	30.3%
2	STRIDES PHARMA SCIENCE LIMITED

Top Countries Importing Roxithromycin from India

30 destination markets · Ranked by import value

All 30 countries →

Top Countries Importing Roxithromycin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	VIETNAM	$1.4M	33.9%
2	CAMBODIA	$763.2K	18.3%
3	AUSTRALIA	$758.8K	18.2%
4	NEW ZEALAND	$405.4K	9.7%
5	MYANMAR	$233.2K	5.6%
6	GERMANY	$165.4K	4.0%
7	MADAGASCAR	$144.5K	3.5%
8	FRANCE	$77.7K	1.9%
9	CHINA	$43.0K	1.0%
10	THAILAND	$42.3K	1.0%

VIETNAM is India's largest roxithromycin export destination, absorbing 33.9% of total exports worth $1.4M. The top 5 importing countries — VIETNAM, CAMBODIA, AUSTRALIA, NEW ZEALAND, MYANMAR — together account for 85.6% of India's total roxithromycin export value. The remaining 25 destination countries collectively receive the other 14.4%, indicating a focused distribution strategy targeting key markets.

Who Supplies Roxithromycin to India?

1 origin countries · Total import value: $752

India imports roxithromycin from 1 countries with a combined import value of $752. The largest supplier is GERMANY ($752, 4 shipments), followed by . All values are from Indian Customs (DGFT) import records.

Countries Supplying Roxithromycin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$752	4	100.0%

GERMANY is the largest supplier of roxithromycin to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Roxithromycin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, Roxithromycin does not have any approved Abbreviated New Drug Applications (ANDAs) listed in the FDA's Orange Book. This absence indicates that Roxithromycin is not currently approved for marketing in the United States. Consequently, there are no recent approvals, import alerts, or established regulatory pathways for Roxithromycin in the U.S. market. Given that 78 Indian exporters are active in the Roxithromycin market, the lack of U.S. approval suggests a strategic focus on markets with existing regulatory acceptance.

2EU & UK Regulatory Framework

In the European Union, the European Medicines Agency (EMA) oversees the approval and regulation of medicinal products. Roxithromycin has received marketing authorization in several EU member states, indicating compliance with the EMA's stringent requirements for safety, efficacy, and quality. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorizations for Roxithromycin, ensuring adherence to UK-specific regulatory standards. Manufacturers exporting to these regions must comply with Good Manufacturing Practice (GMP) guidelines as stipulated by the EMA and MHRA to maintain market access.

3WHO Essential Medicines & Global Standards

Roxithromycin is not listed on the World Health Organization's (WHO) Model List of Essential Medicines as of the 24th edition published in September 2025. This exclusion suggests that, while effective, Roxithromycin is not considered essential for addressing priority health needs on a global scale. Regarding pharmacopoeial standards, Roxithromycin is included in the British Pharmacopoeia (BP) and the European Pharmacopoeia (EP), providing standardized quality benchmarks for its production and quality control.

4India Regulatory Classification

In India, Roxithromycin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. This classification mandates that Roxithromycin can only be sold with a valid prescription from a registered medical practitioner. The National Pharmaceutical Pricing Authority (NPPA) has not set a ceiling price for Roxithromycin, allowing market-driven pricing within the country. For export purposes, manufacturers must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national export regulations.

5Patent & Exclusivity Status

Roxithromycin's primary patents have expired, leading to the availability of generic versions in various markets. This expiration has intensified competition among manufacturers, particularly in regions where Roxithromycin holds significant market share. The presence of 78 active Indian exporters underscores the competitive landscape and the strategic importance of Roxithromycin in India's pharmaceutical export portfolio.

6Recent Industry Developments

In May 2025, the WHO updated its Model List of Essential Medicines, and Roxithromycin was not included in the 24th edition. This decision reflects the organization's assessment of global health priorities and the availability of alternative treatments.

In January 2026, the WHO emphasized the importance of essential medicines in treating priority health-care needs, highlighting the need for medicines to be available, affordable, and of assured quality at all times. While Roxithromycin is not listed as an essential medicine, its role in treating bacterial infections remains significant in various markets. (who.int)

These developments underscore the dynamic nature of the pharmaceutical industry and the importance of staying informed about regulatory changes and market trends.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Roxithromycin

Retail & reference prices across 9 markets vs. India FOB export price of $14.67/unit

Global Price Benchmark for Roxithromycin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	Not available	USD	Roxithromycin is not approved by the U.S. Food and Drug Administration (FDA) and is therefore not available in the U.S. market.
United Kingdom	Not available	GBP	Specific pricing data for Roxithromycin in the UK is not readily available.
Germany	Not available	EUR	Specific pricing data for Roxithromycin in Germany is not readily available.
Australia	Not available

Supply Chain Risk Assessment — Roxithromycin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Roxithromycin, a macrolide antibiotic, is predominantly manufactured in India. However, the production of its Active Pharmaceutical Ingredient (API) heavily relies on Key Starting Materials (KSMs) sourced from China. This dependency is part of a broader trend where China controls approximately 70–80% of global KSM supply and 60–70% of intermediate supply, making it a critical player in the pharmaceutical supply chain.

Recent geopolitical tensions have exacerbated this vulnerability. In February 2026, the closure of the Strait of Hormuz disrupted the supply of essential chemicals and petrochemicals from the Middle East, leading to increased costs and logistical challenges for API manufacturers in India. This disruption underscores the risks associated with over-reliance on specific regions for critical raw materials.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data from 2022 to 2026 indicates that the top five Indian exporters of Roxithromycin account for 70.6% of total exports, with BRAWN LABORATORIES LIMITED alone contributing 30.3%. This high supplier concentration poses a significant risk, as any operational or compliance issues within these key companies could disrupt the entire supply chain.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme aimed at reducing import dependence on critical APIs and KSMs. Notably, in November 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and Clavulanic Acid, marking a significant step towards self-reliance.

Access Complete Roxithromycin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 427 transactions across 30 markets.

Request Demo View Pricing

Frequently Asked Questions — Roxithromycin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top roxithromycin exporters from India?

The leading roxithromycin exporters from India are BRAWN LABORATORIES LIMITED, STRIDES PHARMA SCIENCE LIMITED, MARKSANS PHARMA LIMITED, and 9 others. BRAWN LABORATORIES LIMITED leads with 30.3% market share ($1.3M). The top 5 suppliers together control 70.6% of total export value.

What is the total export value of roxithromycin from India?

The total export value of roxithromycin from India is $4.2M, recorded across 427 shipments from 78 active exporters to 30 countries. The average shipment value is $9.8K.

Which countries import roxithromycin from India?

India exports roxithromycin to 30 countries. The top importing countries are VIETNAM (33.9%), CAMBODIA (18.3%), AUSTRALIA (18.2%), NEW ZEALAND (9.7%), MYANMAR (5.6%), which together account for 85.6% of total export value.

What is the HS code for roxithromycin exports from India?

The primary HS code for roxithromycin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Roxithromycin

Roxithromycin

Top Roxithromycin Exporters from India

Top Countries Importing Roxithromycin from India

Who Supplies Roxithromycin to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Regulatory Landscape — Roxithromycin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Roxithromycin

Supply Chain Risk Assessment — Roxithromycin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Roxithromycin Trade Intelligence

Frequently Asked Questions — Roxithromycin Exports from India

Who are the top roxithromycin exporters from India?

What is the total export value of roxithromycin from India?

Which countries import roxithromycin from India?

What is the HS code for roxithromycin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of roxithromycin exports from India?

Which ports handle roxithromycin exports from India?

Why is India a leading exporter of roxithromycin?

What certifications do Indian roxithromycin exporters need?

How many buyers import roxithromycin from India?

What is the market share of the top roxithromycin exporter from India?

Analysis Methodology